Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Hematopoietic stem cell transplantation nonmyeloablative

Baron F, Sandmaier BM. Current status of hematopoietic stem cell transplantation after nonmyeloablative conditioning. Curr Opin Hematol 2005 12 435 43. [Pg.1465]

Voltarelli J, Couri C, Stracieri A, et al Autologous nonmyeloablative hematopoietic stem cell transplantation 15 in newly diagnosed type 1 diabetes mellitus. JAMA 2007 297 1568-1576. [Pg.219]

Fukuda T, Boeckh M, Carter RA, Sandmaier BM, Maris MB, Maloney DG, Martin PJ, Storb RF, Marr KA. Risks and outcomes of invasive fungal infections in recipients of allogenic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003 102 827-33. [Pg.65]

HLA human leukocyte antigen HSCT hematopoietic stem cell transplantation hyper-CVAD high-dose methotrexate and cytarabine alternating with fractionated cyclophosphamide plus vincristine, doxorubicin, and dexamethasone IBMTR International Bone Marrow Transplant Registry IL-2 interleukin-2 MDS myelodysplastic syndrome MLL mixed lineage leukemia MUD matched unrelated donor NCCN National Comprehensive Cancer Network NST nonmyeloablative stem cell transplant OS overall survival Ph+ Philadelphia chromosome PML promyelocytic leukemia (gene)... [Pg.2507]

Tabbara lA, Ingram RM. Nonmyeloablative therapy and allogeneic hematopoietic stem cell transplantation. Exp Hematol 2003 31 559-566. [Pg.2556]

Junghanss C, Marr KA, Carter RA, et al. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation a matched control study. Biol Blood Marrow Transplant 2002 8 512-520. [Pg.2557]

Mielcarek M, Martin PJ, Leisenring W, et al. Graft-versus host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003 102 756-762. [Pg.2557]

Nichols WG, Guthrie KA, Corey L, Boeckh M (2004) Influenza infections after hematopoietic stem cell transplantation risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 39 1300-1306 Nusair S, Breuer R, Shapira MY, Berkman N, Or R (2004) Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation. Eur Respir J 23 440-445... [Pg.209]


See other pages where Hematopoietic stem cell transplantation nonmyeloablative is mentioned: [Pg.2548]    [Pg.2548]   
See also in sourсe #XX -- [ Pg.2542 , Pg.2548 , Pg.2548 ]




SEARCH



Cell transplantation

Hematopoietic

Hematopoietic cells

Hematopoietic stem cell transplants

© 2024 chempedia.info